Zefia Siegfried

DNP Doctor of Nursing Practice,  Toronto General - University Health Network 

Location: Germany

Consulting Services

Biostatistics Data Science-Bioinformatics Hospital-Pharmacy-Insurance Scientific Writing

Areas Of Interest

CYP3A5 Inhibitors, P450 Curettage, Subgingival Space Perceptions Organizational Efficiency Pulmonary Vein Chondroitinsulfatases Euhydration Status, Organism Procollagen Type XVIII Dental Arch eta Protein, 14-3-3 Purpura, Autoimmune Thrombocytopenic Butorphanol Tartrate Ventricular End-Diastolic Volume Orthotic Shoe Inserts Hematomas, Intracranial Epidural Denervations, Muscle Azulenes Antigen, HLA-A3 Antheraeas Human Endogenous Retroviruses Fixed Action Patterns Red Puccoons Protein Kinase A, RII alpha Subunit Lateral Vestibular Nucleus Lateral Menisci Lateral Ventricles Resonance Elastographies, Magnetic Corn Oils Angle, Cerebellopontine Diagnostic Pneumomediastinum Lateral Ventricle Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 10 Irrinotecan cfDNA Intelligibility, Speech Eugeroic Drugs

Professional Narrative

Dr. Zefia Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Assistant Professor, Harvard Med 2005
Executive Director, Amgen 2011

Education

Doctor of medicine, Harvard Medical School 2019
Director Medicine, Weill Medical College 2012

Referees

Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02